This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Chinese drug developer Zai Labs Ltd. completed its initial public offering in the US, netting $160mm through the sale of 9.58mm American Depositary Shares (including the overallotment; representing 9.58mm common) at $18 per ADS. Earlier this month, the company stated that it hoped to sell 5.88mm ADSs at a range of $16-18.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?